Gainers
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.
- Ocuphire Pharma (NASDAQ:OCUP) shares increased by 26.39% to $2.63. The company's market cap stands at $54.1 million. The company's, Q3 earnings came out 2 days ago.
- Hims & Hers Health (NYSE:HIMS) stock moved upwards by 23.16% to $5.69. The company's market cap stands at $1.1 billion. The company's, Q3 earnings came out yesterday.
- Tenaya Therapeutics (NASDAQ:TNYA) shares increased by 20.31% to $2.31. The market value of their outstanding shares is at $95.5 million.
- Regulus Therapeutics (NASDAQ:RGLS) shares increased by 9.55% to $1.72. The market value of their outstanding shares is at $25.1 million.
- ContraFect (NASDAQ:CFRX) shares rose 8.97% to $0.17. The company's market cap stands at $6.6 million.
Losers
- Athersys (NASDAQ:ATHX) shares fell 44.7% to $1.25 during Tuesday's pre-market session. The company's market cap stands at $381.3 million.
- Nexalin Technology (NASDAQ:NXL) stock fell 17.94% to $1.35. The market value of their outstanding shares is at $9.8 million.
- Marinus Pharma (NASDAQ:MRNS) stock decreased by 17.65% to $4.62. The company's market cap stands at $171.8 million. As per the news, the Q3 earnings report came out yesterday.
- Roivant Sciences (NASDAQ:ROIV) stock decreased by 12.97% to $4.9. The company's market cap stands at $3.4 billion.
- NeuroMetrix (NASDAQ:NURO) stock decreased by 8.94% to $1.63. The company's market cap stands at $12.6 million.
- Sonendo (NYSE:SONX) shares decreased by 8.92% to $1.84. The company's market cap stands at $91.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
